Catherine M. Szyman
CIK 1438538 · CEO · last filed 2026-03-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$11.52M
Companies
5
Total Filings
115
Lifetime Open-Market Net
-$46.57M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MASI | CEO | 8,674 | $179.95 | $1.56M | $0 | 5 | 2026-03-16 |
| Inari Medical, Inc. (NARI) Delisted | Director | 0 | $79.97 | $0 | $533.7K | 8 | 2025-02-19 |
| EW | CVP, Critical Care | 81,287 | $85.11 | $6.92M | -$42.15M | 88 | 2024-09-03 |
| OM | Director | 24,596 | $4.49 | $110.4K | $0 | 4 | 2023-05-31 |
| MDT | SrVP & Pres Diabetes | 36,521 | $80.20 | $2.93M | -$4.95M | 10 | 2014-03-21 |
Recent Filings · Page 2 of 12
115 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-09 | EW | Mixed | +31,416 | -$51.8K | EDGAR |
| 2024-05-06 | EW | Mixed | +1,875 | -$334.2K | EDGAR |
| 2024-04-26 | Inari Medical, Inc. (NARI) Delisted | Grant (A) | +4,126 | $175.0K | EDGAR |
| 2024-02-23 | EW | Grant (A) | +8,560 | $0 | EDGAR |
| 2024-02-15 | EW | Mixed | — | -$2.31M | EDGAR |
| 2023-10-10 | EW | Mixed | — | -$179.7K | EDGAR |
| 2023-09-08 | EW | Mixed | — | -$196.2K | EDGAR |
| 2023-08-09 | EW | Mixed | — | -$209.4K | EDGAR |
| 2023-07-10 | EW | Mixed | −252 | -$291.6K | EDGAR |
| 2023-06-13 | EW | Mixed | — | -$245.3K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.